MET: Form 144 — Proposed Sale of 221 Shares ($17,474)
MetLife, Inc. (MET) filed a Form 144 reporting a proposed sale of 221 shares of common stock through Bernstein Institutional Services LLC with an aggregate market value of $17,474.47.
Rhea-AI Filing Summary
MetLife, Inc. (MET) filed a Form 144 reporting a proposed sale of 221 shares of common stock through Bernstein Institutional Services LLC with an aggregate market value of $17,474.47. The notice lists the company’s outstanding shares as 665,026,054 and an approximate sale date of 09/19/2025. The shares were originally acquired on 05/29/2015 in a purchase from Goldman Sachs with cash payment on 06/03/2015. The filing also discloses several recent sales by MetLife-related accounts between 06/20/2025 and 07/31/2025 totaling multiple transactions and varying gross proceeds.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small scheduled insider sale; disclosed per Rule 144 with recent related-account sales noted; appears immaterial to market capitalization.
The form documents a proposed sale of 221 shares valued at $17,474.47 against total outstanding shares of 665,026,054, indicating the transaction is extremely small relative to the company’s float. The filer reports acquisition details (05/29/2015 purchase from Goldman Sachs) and cash payment on 06/03/2015, meeting Rule 144 disclosure requirements. The filing also lists several recent sales by MetLife-managed accounts with specified quantities and gross proceeds, which provide context but do not, by themselves, indicate material shifts in ownership or control.
TL;DR: Documentation complies with Rule 144 disclosure norms; no material adverse facts presented in the notice.
The submission includes broker details, acquisition history, payment method, and recent aggregated sales by MetLife-related accounts. The filer’s attestation that they are unaware of undisclosed material adverse information is present. From a compliance perspective, the form contains the expected elements to satisfy Rule 144 reporting for an intended sale and records previous transactions relevant to aggregation rules.
FAQ
What does MET's Form 144 report?
When is the approximate sale date listed on MET's Form 144?
Who is the broker named for the proposed sale in MET's filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.